Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes

Z Fu, E R. Gilbert, D Liu - Current diabetes reviews, 2013 - benthamdirect.com
Pancreatic β-cell dysfunction plays an important role in the pathogenesis of both type 1 and
type 2 diabetes. Insulin, which is produced in β-cells, is a critical regulator of metabolism …

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

GF Lewis, A Carpentier, K Adeli, A Giacca - Endocrine reviews, 2002 - academic.oup.com
The primary genetic, environmental, and metabolic factors responsible for causing insulin
resistance and pancreatic β-cell failure and the precise sequence of events leading to the …

Glucolipotoxicity: fuel excess and β-cell dysfunction

V Poitout, RP Robertson - Endocrine reviews, 2008 - academic.oup.com
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed
to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary …

Glucolipotoxicity of the pancreatic beta cell

V Poitout, J Amyot, M Semache, B Zarrouki… - … et Biophysica Acta (BBA …, 2010 - Elsevier
The concept of glucolipotoxicity refers to the combined, deleterious effects of elevated
glucose, and fatty acid levels on pancreatic beta-cell function and survival. Significant …

Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death

W El-Assaad, J Buteau, ML Peyot, C Nolan… - …, 2003 - academic.oup.com
We have proposed the “glucolipotoxicity” hypothesis in which elevated free fatty acids
(FFAs) together with hyperglycemia are synergistic in causing islet β-cell damage because …

Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.

B Soria, E Roche, G Berná, T León-Quinto, JA Reig… - Diabetes, 2000 - Am Diabetes Assoc
Embryonic stem (ES) cells display the ability to differentiate in vitro into a variety of cell
lineages. Using a cell-trapping system, we have obtained an insulin-secreting cell clone …

Malonyl-CoA, fuel sensing, and insulin resistance

NB Ruderman, AK Saha, D Vavvas… - American Journal of …, 1999 - journals.physiology.org
Malonyl-CoA is an allosteric inhibitor of carnitine palmitoyltransferase (CPT) I, the enzyme
that controls the transfer of long-chain fatty acyl (LCFA)-CoAs into the mitochondria where …

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

N Ruderman, M Prentki - Nature reviews Drug discovery, 2004 - nature.com
Patients with the metabolic syndrome are characterized by insulin resistance, obesity and a
predisposition to hypertension, dyslipidaemia, pancreatic β-cell dysfunction, type 2 diabetes …

Molecular mechanisms of insulin resistance and associated diseases

B Mlinar, J Marc, A Janež, M Pfeifer - Clinica chimica acta, 2007 - Elsevier
Insulin resistance is a state in which higher than normal concentrations of insulin are
required for normal response. The most common underlying cause is central obesity …

Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes

M Prentki, E Joly, W El-Assaad, R Roduit - Diabetes, 2002 - Am Diabetes Assoc
β-Cells possess inherent mechanisms to adapt to overnutrition and the prevailing
concentrations of glucose, fatty acids, and other fuels to maintain glucose homeostasis …